O -GlcNAcylation of the Tumor Suppressor FOXO3 Triggers Aberrant Cancer Cell Growth

Cancer Research
Heon ShinYoung-Ki Paik

Abstract

Posttranslational modifications of tumor suppressors can induce abnormal cell growth. Here, we identify site-specific O-GlcNAcylation as a critical block of FOXO3 that may abrogate a part of the p53 pathway, resulting in aberrant cancer cell growth. Of seven O-GlcNAcylation sites identified within the FOXO3 transactivation domain, we found that changes in O-GlcNAcylation at Ser284 modulated p21-mediated cancer cell growth. Overexpression of either O-GlcNAcylated FOXO3 (FOX-OV) or a Ser-to-Ala mutant (S284A) in PANC-1 cells indicated that S284 O-GlcNAc acts as a critical block of the FOXO tumor suppressor and induces proliferation in PANC-1 cancer cells by stimulating the MDM2-p53-p21 axis. Furthermore, S284A mutant cells lacking S284 O-GlcNAc and FOX-OV cells exhibited opposing MDM2-p53-p21 axis expression patterns at both the mRNA and protein levels. Thus, our study provides evidence to support a role for S284 O-GlcNAc as a critical block of FOXO3 to induce subsequent cancer cell growth via abrogation of the p53 regulatory circuit.Significance: These findings highlight a posttranslational mechanism for indirect abrogation of the p53 pathway, one that may occur with some frequency in human cancer cells. Cancer Res; 78(5); 1214-...Continue Reading

References

Dec 10, 1998·Nucleic Acids Research·H OgataM Kanehisa
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·J P CondreayT A Kost
May 18, 2000·JAMA : the Journal of the American Medical Association·S M GapsturA Dyer
Aug 2, 2000·Trends in Endocrinology and Metabolism : TEM·K H Kaestner
Mar 10, 2004·The Biochemical Journal·Lars P Van Der HeideMarten P Smidt
Jan 20, 2006·Nature Chemical Biology·Gerald W Hart
Jul 25, 2007·Journal of Cell Science·Haojie Huang, Donald J Tindall
Jan 22, 2008·Nature Cell Biology·Jer-Yen YangMien-Chie Hung
Apr 19, 2008·The Journal of Biological Chemistry·Michael P HousleyGerald W Hart
Oct 28, 2008·Molecular Cell·Ryan D Michalek, Jeffrey C Rathmell
Dec 24, 2008·The Journal of Biological Chemistry·Michael P HousleyGerald W Hart
Mar 27, 2009·The Journal of Biological Chemistry·Wei FuWenlong Bai
Jul 15, 2009·Methods in Molecular Biology·Huaiyu Mi, Paul Thomas
Nov 27, 2009·The Journal of Biological Chemistry·Jeeyong LeeYoung-Ki Paik
Apr 27, 2011·Cell Cycle·Thomas P Lynch, Mauricio J Reginato
Sep 3, 2011·Cell·James R Downing
Aug 28, 2012·Science·Wen YiLinda C Hsieh-Wilson
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jun 26, 2013·Nature Reviews. Cancer·Eric W-F LamChuay-Yeng Koo
Aug 22, 2013·Frontiers in Endocrinology·Yann FardiniTarik Issad
Sep 3, 2013·Expert Review of Proteomics·Junfeng Ma, Gerald W Hart
Jan 15, 2014·Molecular Cancer Therapeutics·Kartick C PramanikSanjay K Srivastava
Jun 12, 2014·Frontiers in Oncology·Rafaela Muniz de QueirozWagner Barbosa Dias
Jul 18, 2015·Redox Biology·Lars-Oliver KlotzMaria Monsalve
Nov 19, 2015·Nucleic Acids Research·Huaiyu MiPaul D Thomas
Jan 19, 2016·Trends in Biochemical Sciences·Maria V Liberti, Jason W Locasale
Dec 3, 2016·Nucleic Acids Research·Minoru KanehisaKanae Morishima
Apr 22, 2017·Cell·Brendan D Manning, Alex Toker

❮ Previous
Next ❯

Citations

Oct 1, 2019·The American Journal of Surgical Pathology·Jen-Chieh LeeYu-Chien Kao
Jul 6, 2019·BMC Biology·Neha M AkellaMauricio J Reginato
Apr 7, 2021·Cellular Signalling·Lan HuYuanyuan Ruan
Jun 14, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaodong HaoYunshan Wang
Nov 19, 2020·Journal of Proteome Research·Keun NaYoung-Ki Paik
Oct 10, 2021·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Patrick LebokEike Burandt
Oct 6, 2021·The FEBS Journal·Tianshu Gui, Boudewijn M T Burgering

❮ Previous
Next ❯

Related Concepts